Lewi
Jeremy W. Lewi, La Jolla, CA US
Patent application number | Description | Published |
---|---|---|
20110016068 | CONSTANT MEMORY IMPLEMENTATION OF A PHASE-MODEL NEURAL NETWORK - Disclosed are systems, apparatuses, and methods for implementing a phase-model neural network using a fixed amount of memory. Such a phase-model neural network includes a plurality of neurons, wherein each neuron is associated with two parameters—an activity and a phase. Example methods include (i) generating a sequence of variables associated with a probability distribution of phases and (ii) sequentially sampling the probability distribution of phases using a fixed amount of memory, regardless of a number of phases used in the phase-model neural network. | 01-20-2011 |
Paulas Joannes Lewi, Turnhout BE
Patent application number | Description | Published |
---|---|---|
20140323488 | DISUBSTITUTED TRIAZINE DIMERS FOR TREATMENT AND/OR PREVENTION OF INFECTIOUS DISEASES - The present invention relates to novel compounds (I) containing two disubstituted triazine rings covalently linked by an organic linker, thereby creating dimers. These compounds show activity against the causative infective agents of infectious diseases such as African trypanosomiasis, Chagas disease, Leishmaniasis, Malaria and HIV. The invention further relates to the prevention and/or treatment of these diseases. | 10-30-2014 |
Paulus Joannes Lewi, Turnhout BE
Patent application number | Description | Published |
---|---|---|
20080262007 | Hiv Inhibiting 5-Substituted Pyrimidines - HIV replication inhibitors of formula | 10-23-2008 |
20080287511 | Anthelmintic Imidazol-Thiazole Derivates - The present invention relates to the novel anthelmintic compound tetrahydro-furan-2-carboxylic acid-[3-(2,3,5,6-tetrahydro-imidazo[2,1-b]thiazol-6-yl)-phenyl]-amide and the pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, as well as pharmaceutical compositions comprising said novel compound, processes for preparing said compound and compositions, and the use thereof as a medicine, in particular in treatment, control and prevention of endo- and ectoparasite infections in warm-blooded animals. | 11-20-2008 |
20090012092 | Hiv Inhibiting 1,2,4-Triazin-6-One Derivatives - The present invention relates to HIV replication inhibitors of formula | 01-08-2009 |
20090124644 | HIV INHIBITING 2-(4-CYANOPHENYLAMINO) PYRIMIDINE DERIVATIVES - HIV replication inhibitors of formula | 05-14-2009 |
20090181993 | HIV INHIBITING 5-HETEROCYCLYL PYRIMIDINES - HIV replication inhibitors of formula (I), N-oxides, pharmaceutically acceptable addition salts, quaternary amines or stereoisomeric forms thereof, wherein -a | 07-16-2009 |
20110077261 | PREVENTION OF HIV-INFECTION - This invention relates to the use of a parenteral formulation comprising the NNRTI TMC278 for the long term prevention of HIV infection in a subject at risk of being infected by HIV, which comprises the intermittent administration of the said formulation at long time intervals. | 03-31-2011 |
20120076835 | HIV INHIBITING PYRIMIDINES DERIVATIVES - This invention concerns HIV replication inhibitors of formula | 03-29-2012 |
20120190697 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES - HIV replication inhibitors of formula | 07-26-2012 |
Paulus Joannes Lewi, Tumhout BE
Patent application number | Description | Published |
---|---|---|
20100034810 | PYRIMIDINE DERIVATIVES FOR THE PREVENTION OF HIV INFECTION - This invention concerns the use of a compound for the manufacture of a medicament for the prevention of HIV infection via sexual intercourse and related intimate contact between partners, wherein the compound is a compound of formula | 02-11-2010 |
Paulus Joannes Lewi, Turnhout NL
Patent application number | Description | Published |
---|---|---|
20140343006 | HIV Replication Inhibiting Pyrimidines - This invention concerns HIV replication inhibitors of formula | 11-20-2014 |
Wim Lewi US
Patent application number | Description | Published |
---|---|---|
20140323488 | DISUBSTITUTED TRIAZINE DIMERS FOR TREATMENT AND/OR PREVENTION OF INFECTIOUS DISEASES - The present invention relates to novel compounds (I) containing two disubstituted triazine rings covalently linked by an organic linker, thereby creating dimers. These compounds show activity against the causative infective agents of infectious diseases such as African trypanosomiasis, Chagas disease, Leishmaniasis, Malaria and HIV. The invention further relates to the prevention and/or treatment of these diseases. | 10-30-2014 |